• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria News / The Global Fund to Fight AIDS, Tuberculosis and Malaria Welcomes Passage of 2011 U.S. Budget

The Global Fund to Fight AIDS, Tuberculosis and Malaria Welcomes Passage of 2011 U.S. Budget

April 18, 2011 By Malaria.com Leave a Comment

The Global Fund to Fight AIDS, Tuberculosis and Malaria has welcomed passage of the continuing resolution for the Fiscal Year 2011 U.S. budget which contains a US$1.05 billion contribution to The Global Fund.

“I offer my sincere thanks to the U.S. on behalf of the millions of people around the world who benefit from resources channeled through The Global Fund. I am grateful to President Obama and the U.S. Congress for this vote of confidence in the Global Fund and for standing firm by U.S. commitments to global health despite significant pressure to reduce budget deficits,” said Professor Michel Kazatchkine, Executive Director of The Global Fund. “Tens of thousands of lives will be saved as a direct result of this budget. And I hope that it will inspire other countries to follow the lead of the United States.”

With total commitments of more than US$ 22 billion to grants in 145 countries, The Global Fund provides two thirds of all international funding to fight TB and malaria and supports programs providing AIDS treatment to more than half of all the people who need it in the developing world. The United States contributions make up nearly one third of the total commitments to the Global Fund.

During testimony before the House Appropriations Subcommittee on State, Foreign Operations and Related Programs last Thursday just hours before the vote in the House and the Senate, Dr. Christoph Benn, the Global Fund’s Director of External Relations and Partnerships, thanked the Obama Administration and Congress for their continued support leading to a bipartisan effort to protect international health funding despite the significant budgetary pressures.

“The Global Fund fully understands that these are difficult economic times and that hard choices have to be made,” Dr Benn told the committee. “However, the resources allocated to the Global Fund, as well as the U.S. bilateral programs PEPFAR and PMI, represent excellent value for money.” Dr. Benn made clear that with continued U.S. leadership, The Global Fund can leverage U.S. funding so we can “turn the corner on the three diseases and increase stability, growth and security around the globe.”

Source: The Global Fund to Fight AIDS, Tuberculosis and Malaria

Filed Under: Malaria News Tagged With: Christoph Benn, Global Fund, Global Fund to Fight AIDS Tuberculosis and Malaria, Michel Kazatchkine

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

Five Things You Might Not Know About Medicine Quality

The proliferation of poor quality medicines has been described as a global pandemic that threatens the lives of millions.1 It stands to reason that poor quality medicines are not going to improve anyone’s health, but how much do we really know about the quality of medicines used across the world? Here we examine five issues relating to medicine quality in an effort to show why we should all be paying more attention to a serious public health issue that is difficult to tackle and not yet fully understood.

How Can We Detect Poor Quality Medicines?

Finding out what medicines contain and investigating their packaging are vital steps in the fight against poor quality medicines, both substandard and falsified. Falsified medicines usually masquerade as real medicines by copying the appearance and packaging of the real product, but may not contain any of the same active ingredients, or in the correct amounts.

Challenges in Tackling the Issue of Poor Quality Medicines

There are many unresolved issues that impede the elimination of poor quality medicines, namely: (1) Progress impeded by confusion over definitions; Ensuring a market free of poor quality medicines; and the lack of global criminal laws.

Editorial

Antimicrobial Resistance: The Silent Threat in Malaria Eradication

By Bernard Owusu Agyware, Arielle Dolegui and Jesus Aquilar Malaria is a serious and sometimes deadly disease, affecting millions and claiming more than  600,000 lives worldwide each year in 2022 and 2021.1 Low and Middle-Income Countries (LMICs), particularly in Sub-Saharan Africa, disproportionately bear the greatest burden of malaria. The fight to eradicate this worrisome disease […]

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2026 Malaria.com · Log in